$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
Quick studies: These Kansans just left their college careers for $500K (and a crash course in startups)
When a friend encouraged Aditya Joshi and Varun Verma to apply for the Y Combinator accelerator program, the Wichita natives didn’t expect to land an interview, they shared — much less get accepted. “Truly, all we had was this idea and a couple of months under our belt of just talking to different folks,” Joshi…
Siblings spin family pet into family business, capitalizing on alpaca’s plush potential
One Wyandotte County family’s trip to a local fair inspired their interest in alpacas, but it wasn’t until they brought one of the animals home as a pet that they realized the business opportunities they’d unleashed. “That’s where the idea started of — ‘Hey, we can actually make this an Alpaca clothing company and reduce…
Black Drip releases canned cold brew as KC coffee maker leans into creative blends
A new cold brew version from Charon Thompson’s popular Kansas City coffee brand drips with strength, the co-founder said, teasing its arrival on the market just as the metro begins to heat up for the spring. “I can’t sell hot coffee when it’s like 92 degrees,” said Thompson, recalling an experience during a Black Drip…
GOP lawmaker from Missouri takes over chair of Small Business Caucus in DC
Entrepreneurship and small businesses are the lifeblood of America, said Mark Alford, pledging to use his new leadership role within the Small Business Caucus to help fellow congressmen workshop and pursue policies that will “ensure the safety and prosperity of Main Street America.” U.S. Rep. Alford, R-Missouri, publicly took over the co-chair role of the…